Polymerase Chain Reaction Market, by Product Type (Instrument (Real Time PCR, Digital PCR, Others) Reagents and Consumables)), by End User (Clinical Diagnostics, Academic and Research Laboratories, Forensic Laboratories, Others) - Global Industry Insights

Polymerase Chain Reaction Market, by Product Type (Instrument (Real Time PCR, Digital PCR, Others) Reagents and Consumables)), by End User (Clinical Diagnostics, Academic and Research Laboratories, Forensic Laboratories, Others) - Global Industry Insights, and Forecast, 2022 - 2028

Polymerase chain reaction (PCR) is used to amplify a specific segment of DNA through a thermal cycling protocol. Continuous technological advancement in the field of polymerase chain reaction are aimed to improve specificity, scalability and reliability in DNA amplification and thereby creating millions of amplicons of a target sequence in a short period of time. PCR is used for various applications, including the detection of pathogenic bacteria, disease diagnosis, molecular and genetic research, forensic DNA profiling, and parental testing. Rapid technological advancement in the polymerase chain reaction to deliver highly sensitive and optimized detection instrument, increasing prevalence of chronic and infectious disease, and growing research funding in gene therapy and molecular testing is projected to drive growth of the polymerase chain reaction market over the forecast period.
Market Dynamics
The global polymerase chain reaction market is projected to witness significant growth over the forecast period, owing to its wide and increasing applications in various fields, which include diagnosis of infectious diseases, such as middle ear infections, tuberculosis, Lyme disease, in forensics, including DNA fingerprinting, paternity testing and in various other molecular research applications, such as DNA sequencing, DNA cloning, and gene expression. Polymerase chain reaction is used for diagnosis of genetic disease, allowing to detect inherited genetic change or spontaneous genetic mutation.
PCR is used in personalized medicine to help patients in selecting certain treatments, such as in cancer when patients have a genetic change that makes a patient more or less likely to respond to a certain treatment. Polymerase chain reaction is used to study the molecular characteristics in cancer patients, in order to deliver tailored cancer therapy in lung and colorectal cancer. Real-time PCR offers higher sensitivity and specificity in various range of nucleic acid amplification, which is used in wide research areas including infectious disease research, translational medicine to applied biology. Furthermore, technological advancement in the PCR reagents, assay, instruments and analysis tools, help to provide more customized results in various research areas, such as stem cell research, oncology and genetic disease research, pharmaceutical analytics, pharmacogenomics, plant science research and agriculture biotechnology. Such wide numbers of PCR applications in the different field of healthcare and medical research areas, are estimated to augment growth of the polymerase chain reaction market over the forecast period.
Key features of the study:
This report provides in-depth analysis of the polymerase chain reaction market and its market size (US$ Million) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global polymerase chain reaction market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies
Key companies covered as a part of this study include F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Agilent Technologies, Inc., bioMérieux, S.A., Enzo Life Science, Inc., Abbott Laboratories, Takara Bio Inc., Becton, Dickinson and Company and Danaher Corporation.
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion and marketing tactics.
The global polymerase chain reaction market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for polymerase chain reaction market, research and consulting firms, new entrants and financial analysts.
Detailed Segmentation:
Global Polymerase Chain Reaction Market, By Product Type:
Real Time PCR
Digital PCR
Others
Instrument
Reagents and consumables
Global Polymerase Chain Reaction Market, By End User:
Clinical Diagnostics
Academic and Research Laboratories
Forensic Laboratories
Others
Global Polymerase Chain Reaction Market, By Region:
North America
By Country:
U.S.
Canada
By Product Type:
Instrument
Real Time PCR
Digital PCR
Others
Reagents and consumables
By End User:
Clinical Diagnostics
Academic and Research Laboratories
Forensic Laboratories
Others
Europe
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
By Product Type:
Instrument
Real Time PCR
Digital PCR
Others
Reagents and consumables
By End User:
Clinical Diagnostics
Academic and Research Laboratories
Forensic Laboratories
Others
Asia Pacific
By Country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
By Product Type:
Instrument
Real Time PCR
Digital PCR
Others
Reagents and consumables
By End User:
Clinical Diagnostics
Academic and Research Laboratories
Forensic Laboratories
Others
Latin America
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
By Product Type:
Instrument
Real Time PCR
Digital PCR
Others
Reagents and consumables
By End User:
Clinical Diagnostics
Academic and Research Laboratories
Forensic Laboratories
Others
Middle East
By Country:
GCC
Israel
Rest of Middle East
By Product Type:
Instrument
Real Time PCR
Digital PCR
Others
Reagents and consumables
By End User:
Clinical Diagnostics
Academic and Research Laboratories
Forensic Laboratories
Others
Africa
By Country:
North Africa
Central Africa
South Africa
By Product Type:
Instrument
Real Time PCR
Digital PCR
Others
Reagents and consumables
By End User:
Clinical Diagnostics
Academic and Research Laboratories
Forensic Laboratories
Others
Company Profiles
F. Hoffmann-La Roche Ltd. *
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Bio-Rad Laboratories, Inc.
Thermo Fisher Scientific Inc.
Agilent Technologies, Inc.
bioMérieux, S.A.
Enzo Life Science, Inc.
Abbott Laboratories
Takara Bio Inc.
Becton, Dickinson and Company
Danaher Corporation
“*” marked represents similar segmentation in other categories in the respective section.